Conmed (CNMD) Assets Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Conmed | 1.06 Bn | 1.02 Bn | 183.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.07% |
| Dec 31, 2025 | 0.41% |
| Sep 30, 2025 | 0.44% |
| Jun 30, 2025 | 3.96% |
| Mar 31, 2025 | 8.77% |
| Dec 31, 2024 | 9.30% |
| Sep 30, 2024 | 9.70% |
| Jun 30, 2024 | 9.06% |
| Mar 31, 2024 | 9.76% |
| Dec 31, 2023 | 9.50% |
| Sep 30, 2023 | 10.09% |
| Jun 30, 2023 | 10.45% |
| Mar 31, 2023 | 9.84% |
| Dec 31, 2022 | 8.98% |
| Sep 30, 2022 | 9.24% |
| Jun 30, 2022 | 5.61% |
| Mar 31, 2022 | 0.47% |
| Dec 31, 2021 | 8.86% |
| Sep 30, 2021 | 8.77% |
| Jun 30, 2021 | 8.92% |
| Mar 31, 2021 | 8.96% |
| Dec 31, 2020 | 8.86% |
| Sep 30, 2020 | 8.59% |
| Jun 30, 2020 | 8.89% |
| Mar 31, 2020 | 9.65% |
| Dec 31, 2019 | 10.13% |
| Sep 30, 2019 | 9.73% |
| Jun 30, 2019 | 9.53% |
| Mar 31, 2019 | 9.46% |
| Dec 31, 2018 | 7.51% |
| Sep 30, 2018 | 7.60% |
| Jun 30, 2018 | 7.77% |
| Mar 31, 2018 | 7.47% |
| Dec 31, 2017 | 7.33% |
| Sep 30, 2017 | 7.05% |
| Jun 30, 2017 | 6.76% |
| Mar 31, 2017 | 7.03% |
| Dec 31, 2016 | 6.81% |
| Sep 30, 2016 | 7.08% |
| Jun 30, 2016 | 7.32% |
| Mar 31, 2016 | 7.43% |
| Dec 31, 2015 | 0.70% |
| Sep 30, 2015 | 0.16% |
| Jun 30, 2015 | 0.88% |
| Mar 31, 2015 | 0.35% |
| Dec 31, 2014 | 5.49% |
| Sep 30, 2014 | 3.55% |
| Jun 30, 2014 | 3.14% |
| Dec 31, 2013 | 3.42% |